Preclinical study demonstrates promising treatment for rare bone disease

Researchers have led a preclinical study demonstrating that the drug palovarotene suppresses the formation of bony tumors (osteochondromas) in models of multiple hereditary exostoses (MHE). The research is an important step toward an effective pharmacological treatment for MHE, a rare genetic condition that affects about 1 in 50,000 people worldwide. Source: Feed4

Materialists collect Facebook friends and spend more time on social media

If you’re materialistic, you’re likely to use Facebook more frequently and intensely. A new article reveals that materialistic people see and treat their Facebook friends as ‘digital objects,’ and have significantly more friends than people who are less interested in possessions. It also shows that materialists have a greater need to compare themselves with others […]

Key signaling protein for muscle growth

Researchers have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Researchers have described the protein’s critical role in the growth and repair of skeletal muscles, both in post-natal development and in the regeneration of injured adult muscles. Source: Feed4